These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9697161)

  • 1. Relations between neuropsychological vulnerability markers and negative symptoms in schizophrenia.
    Suslow T; Junghanns K; Weitzsch C; Arolt V
    Psychopathology; 1998; 31(4):178-87. PubMed ID: 9697161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
    Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
    Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vulnerability to schizophrenia. I: Familial nature of of neuropsychologic indicators].
    d'Amato T; Saoud M; Triboulet P; Bertaud JP; Dalery J
    Encephale; 1998; 24(5):442-8. PubMed ID: 9850818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of positive and negative symptoms in schizophrenia. A study from a population of long-term outpatients.
    Palacios-Araus L; Herrán A; Sandoya M; González de la Huebra E; Vázquez-Barquero JL; Díez-Manrique JF
    Acta Psychiatr Scand; 1995 Sep; 92(3):178-82. PubMed ID: 7484194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenic syndrome and Wisconsin Card Sorting Test dimensions.
    Cuesta MJ; Peralta V; Caro F; de Leon J
    Psychiatry Res; 1995 Sep; 58(1):45-51. PubMed ID: 8539311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paranoid schizophrenia: non-specificity of neuropsychological vulnerability markers.
    Suslow T; Arolt V
    Psychiatry Res; 1997 Sep; 72(2):103-14. PubMed ID: 9335201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative symptoms, neurological signs and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia.
    Chen EY; Lam LC; Chen RY; Nguyen DG
    Br J Psychiatry; 1996 Feb; 168(2):227-33. PubMed ID: 8837915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The functional significance of symptomatology and cognitive function in schizophrenia.
    Velligan DI; Mahurin RK; Diamond PL; Hazleton BC; Eckert SL; Miller AL
    Schizophr Res; 1997 May; 25(1):21-31. PubMed ID: 9176924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia?
    Halari R; Mehrotra R; Sharma T; Kumari V
    Schizophr Bull; 2006 Oct; 32(4):751-7. PubMed ID: 16760421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wisconsin Card Sorting Test performance in schizophrenia: remediation of a stubborn deficit.
    Green MF; Satz P; Ganzell S; Vaclav JF
    Am J Psychiatry; 1992 Jan; 149(1):62-7. PubMed ID: 1728187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function in schizophrenia: association with negative and positive symptoms.
    Capleton RA
    Psychol Rep; 1996 Feb; 78(1):123-8. PubMed ID: 8839306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression, psychomotor retardation, negative symptoms, and memory in schizophrenia.
    Brébion G; Amador X; Smith M; Malaspina D; Sharif Z; Gorman JM
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul; 13(3):177-83. PubMed ID: 10910088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illness.
    Binder J; Albus M; Hubmann W; Scherer J; Sobizack N; Franz U; Mohr F; Hecht S
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(2):70-7. PubMed ID: 9684915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test.
    Nieuwenstein MR; Aleman A; de Haan EH
    J Psychiatr Res; 2001; 35(2):119-25. PubMed ID: 11377441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vulnerability to schizophrenia: neuropsychological performance and schizotypal personality traits].
    Laurent A; Halim V; Sechier P; Daumal M; Foussard N; Dumas P; Daléry J; d'Amato T
    Encephale; 2001; 27(2):173-9. PubMed ID: 11407270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical symptom dimensions and deficits on the Continuous Performance Test in schizophrenia.
    Liu SK; Hwu HG; Chen WJ
    Schizophr Res; 1997 Jun; 25(3):211-9. PubMed ID: 9264176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations between attentional deficits and clinical symptoms in schizophrenic outpatients.
    Strauss ME; Buchanan RW; Hale J
    Psychiatry Res; 1993 Jun; 47(3):205-13. PubMed ID: 8372159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.